Convection-enhanced Diffusion: A Novel Tactics to Crack the BBB

Area of Science:

• Neurosurgery
• Pharmacology
• Biomedical Engineering

Background:

• The brain's accessibility to nutrients contrasts with the challenge of delivering medications to malignant brain tumors.
• The blood-brain barrier (BBB) restricts the passage of many therapeutic agents.
• Neurological conditions like brain tumors, Parkinson's disease, and epilepsy require effective drug delivery strategies.

Purpose of the Study:

• To introduce convection-enhanced delivery (CED) as a method to bypass the BBB.
• To explain the mechanism and application of CED for targeted drug administration.
• To highlight CED's potential in treating central nervous system (CNS) disorders.

Main Methods:

• CED utilizes pressure gradients to distribute therapeutic agents within the brain.
• Drugs are delivered via stereotactically placed catheters directly into or around the tumor or resection cavity.
• Positive-pressure infusion techniques enable the use of various drug classes, including novel targeted medications.

Main Results:

• CED facilitates targeted drug delivery, overcoming BBB limitations.
• Optimizing infusion volume is crucial to maximize efficacy and minimize side effects from backflow.
• The technique allows for precise drug distribution in the CNS.

Conclusions:

• Convection-enhanced delivery (CED) represents a significant advancement in treating brain tumors and other neurological disorders.
• This method offers a promising approach for delivering therapeutic agents that cannot normally cross the BBB.
• Careful optimization of CED parameters is essential for successful clinical application in CNS disorders.